In gastric cancer, IRX1 acts a tumor suppressor through downregulation of BDKRB2, FGF7, and HIST2H2BE expression and inhibiting angiogenesis and cell proliferation [15]. This evidence concerns the gene BDKRB2 and neoplasm.